PepGen Competitors and Similar CompaniesClear all

PepGen's competitors and similar companies include Audientes.

	PepGen PepGen is a clinical-stage biotechnology company developing next-generation of oligonucleotide therapeutics for the treatment of severe neuromuscular and neurologic diseases.	Audientes Audientes is a biotechnology company that develops treatments for muscle diseases.
Founding Date	Founding Date 2018	Founding Date 2014
Type	Type Public	Type Public
Tags	Tags Technology biotech therapy	Tags Technology biotech therapy
Locations	Locations Boston, US HQ	Locations HQ
Employees	Employees 8127% increase	Employees N/A
Financial
Net income	Net income ($89.7m) (FY, 2025)	Net income (kr10.7m) (FY, 2024)

For sources of this data, please see the company profile

Audientes is a biotechnology company that develops treatments for muscle diseases.

Financial